Description
BioInformatics is offering an exciting promotion bundling the Single Cell Analysis Products report in conjunction with four relevant market briefs from our 2018 Global Assessment Report for the Analytical & Life Science Instrumentation Industries. Containing in-depth market demand and forecast data, along with detailed survey response data from end-users, this bundle can help marketing teams correctly focus their efforts and help product managers create products that outshine the competition.
This package includes:
- The 2017 Market for Single Cell Analysis Products: Convergence of Microfluidics and Omics Platforms
- Microarrays Market Brief, 2017-2022
- Flow Cytometry Market Brief, 2017-2022
- Cell Counters Market Brief, 2017-2022
- Raman Spectroscopy Market Brief, 2017-2022
Originally valued at $10,480, we are offering all 5 publications for $7,500 (a $2980 discount)!
(Click here for the end-user survey report brochure)
(Click here for a sample market brief)
Recent interest in genomics and proteomics has generated demand for analysis of genes and proteins within single cells. Development of tools for single-cell genomic studies has progress, with the ability to amplify both DNA and RNA of individual cells, facilitating targeted DNA sequencing, miRNA analysis and gene-expression studies. Advancements in flow cytometry, microarrays, cell counters, and Raman spectroscopy have enabled progression of single-cell analysis that provides unprecedented capabilities for systematically investigating cellular heterogeneity.
The market briefs each contain data and analysis of the market segments by product, industry, function, and region. Data on instrument pricing and unit volume shipments (new and used) are also included in the demand by product sections. The report goes further in identifying leading vendors, providing vendor share data, and a participation matrix for the different product areas. A short listing of related business developments and significant product introductions is also included to provide a better understanding of the market dynamics.
For more information about our product please email us at reports@gene2drug.com or call us at (703) 778-3080 x19.
